Pharmacogenetic Information on Drug Labels of the Italian Agency of Medicines (AIFA): Actionability and Comparison Across Other Regulatory Agencies

ABSTRACT To plan future steps for the implementation and regulation of pharmacogenetic testing, any issue in the management of pharmacogenetic information by regulatory bodies must be identified. In this paper, an analysis of pharmacogenetic information in the summary of product characteristics (SmC...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Antonino Moschella, Soumaya Mourou, Samantha Perfler, Enrico Zoroddu, Daiana Bezzini, Dorian Soru, Claudia Trignano, Monica Miozzo, Alessio Squassina, Erika Cecchin, Matteo Floris
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2025-02-01
Reeks:	Clinical and Translational Science
Onderwerpen:	AIFA drug labels level of actionability pharmacogenetic testing
Online toegang:	https://doi.org/10.1111/cts.70138
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!